RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC

Xiao-Yan Wang1,2, Sheng-Nan Li1,2, Hui-Fang Zhu1,2

  • 1Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.

Scientific Reports
|May 5, 2017
PubMed

Insights

Response gene to complement 32 (RGC32) is upregulated in colorectal cancer (CRC), promoting tumor growth and spread. RGC32 facilitates epithelial-mesenchymal transition (EMT) in CRC via the Smad/Sip1 pathway, indicating its role in cancer progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Biology

Background:

  • Response gene to complement 32 (RGC32) is a transcription factor regulating cell growth, viability, and differentiation.
  • The role of RGC32 in colorectal cancer (CRC) tumorigenesis and progression requires further investigation.

Purpose of the Study:

  • To elucidate the role of RGC32 in the development and progression of colorectal cancer.
  • To investigate the correlation between RGC32 expression and clinicopathological features and patient survival in CRC.

Main Methods:

  • Analysis of RGC32 expression in human CRC tissues and adjacent normal tissues.
  • In vitro and in vivo studies to assess the effects of RGC32 overexpression on CRC cell proliferation, migration, and tumorigenic growth.
  • Investigation of the underlying molecular mechanisms, including the Smad/Sip1 signaling pathway and epithelial-mesenchymal transition (EMT) markers.

Main Results:

  • RGC32 expression was significantly upregulated in CRC tissues compared to normal tissues.
  • RGC32 expression correlated with invasive and aggressive tumor characteristics and predicted poor patient survival.
  • RGC32 overexpression enhanced CRC cell proliferation, migration, and in vivo tumor growth.
  • RGC32 facilitated EMT in CRC by decreasing E-cadherin and increasing vimentin expression via the Smad/Sip1 pathway.

Conclusions:

  • Overexpression of RGC32 is a significant factor in colorectal cancer progression.
  • RGC32 promotes CRC tumorigenesis and metastasis by facilitating epithelial-mesenchymal transition (EMT).
  • Targeting RGC32 or the Smad/Sip1 pathway may offer therapeutic strategies for CRC.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.9K